{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:06Z","timestamp":1792000986947,"version":"4.4.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.intimp.2024.113017","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T21:15:02Z","timestamp":1724793302000},"page":"113017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Recurrent pericarditis and interleukin (IL)-1 inhibitors"],"prefix":"10.1016","volume":"141","author":[{"given":"Nicola","family":"Principi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lazzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Paglialonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Viafora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Aurelio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113017_b0005","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases","volume":"36","author":"Adler","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2024.113017_b0010","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute Pericarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2024.113017_b0015","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113017_b0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PEC.0b013e31822251ba","article-title":"Children presenting with acute pericarditis to the emergency department","volume":"27","author":"Ratnapalan","year":"2011","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.intimp.2024.113017_b0025","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMcp041997","article-title":"Clinical practice. Acute pericarditis","volume":"351","author":"Lange","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1016\/j.intimp.2024.113017_b0030","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.jacc.2016.07.785","article-title":"Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment","volume":"68","author":"Cremer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0035","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/hrt.2003.026120","article-title":"Relapsing pericarditis","volume":"90","author":"Soler-Soler","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.intimp.2024.113017_b0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40259-022-00537-7","article-title":"Interleukin-1 antagonists for the treatment of recurrent pericarditis","volume":"36","author":"Abadie","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2024.113017_b0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2008.07.024","article-title":"Recurrent pericarditis: infectious or autoimmune?","volume":"8","author":"Brucato","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.autrev.2009.11.021","article-title":"Innate versus acquired immune response in the pathogenesis of recurrent idiopathic pericarditis","volume":"9","author":"Cantarini","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.autrev.2012.07.023","article-title":"Recurrent pericarditis: autoimmune or autoinflammatory?","volume":"12","author":"Maestroni","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0060","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024931","article-title":"Pericarditis and autoinflammation: a clinical and genetic analysis of patients with idiopathic recurrent pericarditis and monogenic systemic autoinflammatory diseases at a national referral center","volume":"11","author":"Peet","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2024.113017_b0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.autrev.2014.10.005","article-title":"Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis","volume":"14","author":"Cantarini","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0075","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11739-018-1842-x","article-title":"Management of idiopathic recurrent pericarditis in adults and in children:a role for IL-1 receptor antagonism","volume":"13","author":"Brucato","year":"2018","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.intimp.2024.113017_b0080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jacbts.2020.11.016","article-title":"The role of NLRP3 inflammasome in pericarditis: potential for therapeutic approaches","volume":"6","author":"Mauro","year":"2021","journal-title":"JACC Basic Transl Sci."},{"key":"10.1016\/j.intimp.2024.113017_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","article-title":"Inflammasome activation and regulation: toward a better understanding of complex mechanisms","volume":"6","author":"Zheng","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.intimp.2024.113017_b0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0095","doi-asserted-by":"crossref","first-page":"2310269","DOI":"10.1080\/08916934.2024.2310269","article-title":"The role of NLRP3 inflammasome in type 2 inflammation related diseases","volume":"57","author":"Xu","year":"2024","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2024.113017_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102785","article-title":"The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities","volume":"20","author":"Galozzi","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with st-segment\u2013elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2024.113017_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103240","article-title":"Immune and non-immune mechanisms that determine vasculitis and coronary artery aneurysm topography in Kawasaki disease and MIS-C","volume":"22","author":"Giryes","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-010-8219-x","article-title":"Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis","volume":"44","author":"Cantarini","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2024.113017_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1267091","article-title":"The role of inflammation in autoimmune disease: a therapeutic target","volume":"14","author":"Xiang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113017_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3083.2010.02432.x","article-title":"Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation","volume":"72","author":"J\u00e4ger","year":"2010","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2024.113017_b0130","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.intimp.2013.08.012","article-title":"A critical role for interleukin-1\u03b2 in the progression of autoimmune diseases","volume":"17","author":"Zhao","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113017_b0135","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.autrev.2019.05.012","article-title":"Targeting the balance of T helper cell responses by curcumin in inflammatory and autoimmune states","volume":"18","author":"Rahimi","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0140","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/PL00001993","article-title":"Cytokine activation in pericardial fluids in different forms of pericarditis","volume":"25","author":"Pankuweit","year":"2000","journal-title":"Herz"},{"key":"10.1016\/j.intimp.2024.113017_b0145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/hrt.2009.187138","article-title":"Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis","volume":"96","author":"Caforio","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.intimp.2024.113017_b0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","article-title":"Cardiac involvement in systemic lupus erythematosus","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113017_b0155","article-title":"The heart and cardiovascular manifestations in rheumatoid arthritis","volume":"45 Suppl 4","author":"Voskuyl","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.113017_b0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.acvd.2009.06.009","article-title":"Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies","volume":"103","author":"Meune","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2024.113017_b0165","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/SMJ.0b013e3181ad4847","article-title":"Cardiac tamponade in Still disease: a review of the literature","volume":"102","author":"Parvez","year":"2009","journal-title":"South. Med. J."},{"key":"10.1016\/j.intimp.2024.113017_b0170","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2459\/JCM.0b013e32833cdca8","article-title":"Cardiological features in idiopathic inflammatory myopathies","volume":"11","author":"Bazzani","year":"2010","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.intimp.2024.113017_b0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/ard.55.7.450","article-title":"Cardiac manifestations in primary Sj\u00f6gren's syndrome","volume":"55","author":"Gy\u00f6ngy\u00f6si","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.113017_b0180","first-page":"54","article-title":"Large pericardial effusion in a family with recurrent pericarditis: a report of probable x-linked transmission","volume":"16","author":"Maggiolini","year":"2011","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0185","first-page":"487","article-title":"The heart matters: contribution of genetic factors in recurrent pericarditis","volume":"21","author":"Perricone","year":"2019","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.intimp.2024.113017_b0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tcm.2020.04.006","article-title":"The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment","volume":"31","author":"Lopalco","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2024.113017_b0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2012.07.019","article-title":"Familial mediterranean fever: new phenotypes","volume":"12","author":"Soriano","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/rheumatology\/keac274","article-title":"Mosaic variants in TNFRSF1A: an emerging cause of tumour necrosis factor receptor-associated periodic syndrome","volume":"62","author":"Assrawi","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.113017_b0205","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2019-216701","article-title":"Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever","volume":"79","author":"Van Gorp","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.113017_b0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-200209000-00002","article-title":"The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder","volume":"81","author":"Hull","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2024.113017_b0215","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","article-title":"Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study","volume":"101","author":"Cantarini","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0220","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00392-012-0422-8","article-title":"Clues to detect tumor necrosis factor receptorassociated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study","volume":"101x","author":"Cantarini","year":"2012","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0225","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4065\/72.9.806","article-title":"Clinical spectrum of familial Hibernian fever: a 14-year follow-up study of the index case and extended family","volume":"72","author":"McDermott","year":"1997","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.intimp.2024.113017_b0230","article-title":"Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever","volume":"14","author":"Okumura","year":"2008","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2024.113017_b0235","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s004310000708","article-title":"Isolated recurrent pericarditis in a patient with familial Mediterranean fever","volume":"160","author":"Tutar","year":"2001","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.intimp.2024.113017_b0240","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2169\/internalmedicine.53.2064","article-title":"Acute pericarditis as the first manifestation of familial Mediterranean fever: A possible relationship with idiopathic recurrent pericarditis","volume":"53","author":"Yoshioka","year":"2014","journal-title":"Intern. Med."},{"key":"10.1016\/j.intimp.2024.113017_b0245","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1378\/chest.81.5.592","article-title":"Pericardial disease in familial Mediterranean fever: An echocardiographic study","volume":"81","author":"Dabestani","year":"1982","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2024.113017_b0250","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/eji.201746947","article-title":"Function and mechanism of the pyrin inflammasome","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.113017_b0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12969-015-0057-1","article-title":"Relationship between clinical findings and genetic mutations in patients with familial Mediterranean fever","volume":"13","author":"Kilic","year":"2015","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.intimp.2024.113017_b0260","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.intimp.2024.113017_b0265","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2174\/1381612824666180116095658","article-title":"The role of colchicine in the treatment of autoinflammatory diseases","volume":"24","author":"Liantinioti","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2024.113017_b0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2014.01.052","article-title":"Unmet needs in the treatment of autoimmunity: from aspirin to stem cells","volume":"13","author":"Chang","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0275","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncpcardio1094","article-title":"Corticosteroid therapy for pericarditis: a double-edged sword","volume":"5","author":"Imazio","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2024.113017_b0280","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.autrev.2019.04.001","article-title":"Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis","volume":"18","author":"Peiffer-Smadja","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0285","doi-asserted-by":"crossref","unstructured":"Anakinra. Editor(s): J.K. Aronson, Meyler's Side Effects of Drugs (Sixteenth Edition), Elsevier, 2016, Pages 367-368.","DOI":"10.1016\/B978-0-444-53717-1.00293-6"},{"key":"10.1016\/j.intimp.2024.113017_b0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2012.05.086","article-title":"Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra)","volume":"160","author":"Vassilopoulos","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0295","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00246-012-0532-0","article-title":"Efficacy of an interleukin-1\u03b2 receptor antagonist (anakinra) in idiopathic recurrent pericarditis","volume":"34","author":"Scardapane","year":"2013","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0300","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00246-013-0663-y","article-title":"Successful treatment of idiopathic recurrent pericarditis with interleukin-1 receptor antagonist (Anakinra)","volume":"34","author":"Camacho-Lovillo","year":"2013","journal-title":"Pediatr. Cardiol"},{"key":"10.1016\/j.intimp.2024.113017_b0305","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.24174","article-title":"Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?","volume":"60","author":"Picco","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113017_b0310","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/ajmg.a.35892","article-title":"Recurrent pericarditis in Myhre syndrome","volume":"161A","author":"Picco","year":"2013","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.intimp.2024.113017_b0315","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.ijcard.2014.09.192","article-title":"Resistant or recurrent acute pericarditis: a new therapeutic opportunity?","volume":"177","author":"Massardier","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0320","first-page":"297","article-title":"A new case of idiopathic recurrent acute pericarditis due to R104Q mutation in TNFRSF1A successfully treated with anakinra: expanding the questions","volume":"32","author":"Emmi","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113017_b0325","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fimmu.2018.01233","article-title":"Treating heart inflammation with interleukin-1 blockade in a case of erdheim-chester disease","volume":"9","author":"Tomelleri","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113017_b0330","first-page":"802","article-title":"Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment","volume":"28","author":"Cantarini","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113017_b0335","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/1756-185X.13029","article-title":"Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant","volume":"20","author":"Camprub\u00ed","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.113017_b0340","first-page":"123","article-title":"A novel mutation in the CIAS1\/NLRP3 gene associated with an unexpected phenotype of cryopyrin-associated periodic syndromes","volume":"32","author":"Insalaco","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113017_b0345","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2459\/JCM.0000000000000520","article-title":"Refractory idiopathic recurrent pericarditis: treatment with interleukin-1 receptor antagonist is an option!","volume":"18","author":"Ozturk","year":"2017","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.intimp.2024.113017_b0350","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/RHU.0b013e3182685857","article-title":"Recurrent cardiac tamponade in a child with newly diagnosed systemic-onset juvenile idiopathic arthritis","volume":"18","author":"Baszis","year":"2012","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113017_b0355","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jccase.2011.07.003","article-title":"A case series and systematic literature review of anakinra and immunosuppression in idiopathic recurrent pericarditis","volume":"4","author":"Scott","year":"2011","journal-title":"J. Cardiol. Cases"},{"key":"10.1016\/j.intimp.2024.113017_b0360","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.autrev.2019.01.005","article-title":"Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients","volume":"18","author":"Dagan","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113017_b0365","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: The AIRTRIP randomized clinical trial","volume":"316","author":"Brucato","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2024.113017_b0370","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487319879534","article-title":"Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study","volume":"27","author":"Imazio","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0375","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jpeds.2014.01.065","article-title":"Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis","volume":"164","author":"Finetti","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.intimp.2024.113017_b0380","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpeds.2022.11.034","article-title":"Pediatric recurrent pericarditis: appropriateness of the standard of care and response to IL-1 blockade","volume":"256","author":"Caorsi","year":"2023","journal-title":"J. Pediatr."},{"key":"10.1016\/j.intimp.2024.113017_b0385","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/FJC.0000000000000847","article-title":"Acute effects of interleukin-1 blockade using anakinra in patients with acute pericarditis","volume":"76","author":"Wohlford","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113017_b0390","doi-asserted-by":"crossref","unstructured":"K.D. Pile, G.G. Graham, S.M. Mahlerd, Interleukin-1 (IL-1) inhibitors: anakinra, rilonacept, and canakinumab, in: Compendium of inflammatory diseases, April 21, 2016 ed.: Basel Birkh\u00e4user; 2016.","DOI":"10.1007\/978-3-7643-8550-7_29"},{"key":"10.1016\/j.intimp.2024.113017_b0395","unstructured":"Food and Drug Administration. FDA approves first treatment for disease that causes recurrent inflammation in sac surrounding heart. Available at: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-first-treatment-disease-causes-recurrent-inflammation-sac-surrounding-heart Accessed on April 10, 2024."},{"key":"10.1016\/j.intimp.2024.113017_b0400","unstructured":"European Medicines Agency. Rilonacept Regeneron- Available at: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/rilonacept-regeneron-previously-arcalyst Accessed on April 10, 2024."},{"key":"10.1016\/j.intimp.2024.113017_b0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jcph.372","article-title":"Rilonacept pharmacokinetics in children with systemic juvenile idiopathic arthritis","volume":"55","author":"Autmizguine","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113017_b0410","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/heartjnl-2020-317928","article-title":"Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial","volume":"107","author":"Klein","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.intimp.2024.113017_b0415","doi-asserted-by":"crossref","unstructured":"A.L. Klein, M. Imazio, P. Cremer, A. Brucato, A. Abbate, F. Fang, et al. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis, N. Engl. J. Med. 384 (2021) 31-41.","DOI":"10.1056\/NEJMoa2027892"},{"key":"10.1016\/j.intimp.2024.113017_b0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2023.04.046","article-title":"Treatment of idiopathic recurrent pericarditis with goflikicept: phase II\/III study results","volume":"82","author":"Myachikova","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2024.113017_b0425","unstructured":"Food and Drug Administration. Ilaris. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/125319s107lbl.pdf Accessed on April 10, 2024."},{"key":"10.1016\/j.intimp.2024.113017_b0430","unstructured":"European Medicines Agency. Ilaris. Available at: https:\/\/www.ema.europa.eu\/en\/search?search_api_fulltext=canakinumab&f%5B0%5D=ema_search_categories%3A83&f%5B1%5D=ema_medicine_bundle%3Aema_medicine&f%5B2%5D=ema_med_status%3A100108&landing_from=73303 Accessed on April 10, 2024."},{"key":"10.1016\/j.intimp.2024.113017_b0435","doi-asserted-by":"crossref","first-page":"P155","DOI":"10.1186\/1546-0096-13-S1-P155","article-title":"A case of corticosteroid-dependent recurrent pericarditis with different response to two IL-1 blocking agents","volume":"13","author":"Theodoropoulou","year":"2015","journal-title":"Pediatr. Rheumatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:37:47Z","timestamp":1731087467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924015388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":87,"alternative-id":["S1567576924015388"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113017","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent pericarditis and interleukin (IL)-1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113017"}}